Research / ASAN / Fundamental state Inspectable configuration
State dimensions Filing 0001477720-22-000046 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.47% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-30.87% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
50.76% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
89.80% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-82.49% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
55.77% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
35.53% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 24 states Self-history eligible
Oct 31, 2021 0/7 normalized Level 3 Jan 31, 2022 0/7 normalized Level 3 Apr 30, 2022 0/7 normalized Level 3 Jul 31, 2022 0/7 normalized Level 3 Oct 31, 2022 4/7 normalized Level 3 Jan 31, 2023 6/7 normalized Level 3 Apr 30, 2023 6/7 normalized Level 3 Jul 31, 2023 6/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 0.87%
Current 0.47%
Delta -0.40% Cash Generation Increased
Previous -34.09%
Current -30.87%
Delta 3.22% Growth Decreased
Previous 57.35%
Current 50.76%
Delta -6.59% Margin Increased
Previous 89.69%
Current 89.80%
Delta 0.11% Profitability Decreased
Previous -79.76%
Current -82.49%
Delta -2.72% R And D Intensity Increased
Previous 54.05%
Current 55.77%
Delta 1.72% Sbc Intensity Increased
Previous 33.08%
Current 35.53%
Delta 2.45% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.